ProCE Banner Activity

PARP Combinations in Prostate Cancer: PARPi Plus Androgen Receptor Inhibitors

Slideset Download
Download these slides from a live Webinar to gain expert insight on the rationale for combining PARP inhibitors and AR-directed therapy in mCRPC including the latest evidence from ASCO GU 2021.

Released: February 19, 2021

Expiration: February 18, 2022

Share

Faculty

Neal D. Shore

Neal D. Shore, MD, FACS

Director
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only

Faculty Disclosure

Primary Author

Neal D. Shore, MD, FACS

Director
Carolina Urologic Research Center
Atlantic Urology Clinics
Myrtle Beach, South Carolina